Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03623464 · ClinicalTrials.gov registry record · NA
RCT of Mobile Apps & FitBit v. Usual Care
A NA study of Pancreatic Cancer and Gastric Cancer, sponsored by Weill Medical College of Cornell University.
- Active
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT03623464 is a NA study of Pancreatic Cancer and Gastric Cancer that is active but no longer recruiting, run by Weill Medical College of Cornell University. The registered enrollment target is 107 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03623464, a NA study of Pancreatic Cancer and Gastric Cancer, is active but no longer recruiting, sponsored by Weill Medical College of Cornell University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.
Conditions Studied
Interventions
- OTHER Standard of care
- OTHER Mobile health application and Fitbit + standard of care
Study Locations (1)
New York
- Weill Cornell Medicine- New York Presbyterian - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2017-05-31 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03623464
The ClinicalTrials.gov registry entry for NCT03623464 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (73% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT03623464 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03623464 about?
NCT03623464 is a clinical study titled "RCT of Mobile Apps & FitBit v. Usual Care". This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.
What is the current status of trial NCT03623464?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 107 participants. The study started on 2017-05-31. Estimated completion is 2026-06.
What conditions does trial NCT03623464 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Gastric Cancer, Colon Cancer, Rectal Cancer, Hepatic Cancer.
What interventions are being tested in trial NCT03623464?
The interventions under investigation include: Standard of care (OTHER), Mobile health application and Fitbit + standard of care (OTHER).
Who is sponsoring clinical trial NCT03623464?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03623464 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
RECRUITING · NA
-
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
RECRUITING · NA
-
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.